Bacterial meningitis

Handbook of Clinical Neurology

Volumn 121, Issue , 2014, Pages 1361-1375

  Heckenberg, Sebastiaan G B ^a   Brouwer, Matthijs C ^b   Van de Beek, Diederik ^b  

^a Department of Orthopaedic Surgery   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial resistance; Antimicrobial therapy; Bacterial meningitis; Cerebrospinal fluid analysis; Dexamethasone; Meningococcal infections; Pneumococcal infections; Vaccination

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; GLYCEROL;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; GENETICS; HUMAN; MENINGOCOCCOSIS; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PNEUMOCOCCAL INFECTION; PUNCTURE; VACCINATION;

ANTIMICROBIAL RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; DEXAMETHASONE; MENINGOCOCCAL INFECTIONS; PNEUMOCOCCAL INFECTIONS; VACCINATION;

MENINGITIS, BACTERIAL; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; GLYCEROL; HUMANS; SPINAL PUNCTURE;

EID: 84890823566     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4088-7.00093-6     Document Type: Chapter

References (65)

1. Adriani K.S., van de Beek D., Brouwer M.C., et al. Community-acquired recurrent bacterial meningitis in adults. Clin. Infect. Dis. 2007, 45:e46-e51.
2. Ajdukiewicz K.M., Cartwright K., Scarborough M., et al. A double blind randomised controlled trial of glycerol adjuvant therapy in adult bacterial meningitis in a high HIV seroprevalence setting in Malawi. Lancet Infect. Dis. 2011, 11:293-300.
3. Arend S.M., Lavrijsen A.P., Kuijken I., et al. Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:643-649.
4. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003, 3:169-176. [doi];nri1004 [pii]. http://dx.doi.org/101038/nri1004.
5. Brouwer M.C., van de Beek D., Heckenberg S.G., et al. Community-acquired Listeria monocytogenes meningitis in adults. Clin. Infect. Dis. 2006, 43:1233-1238.
6. Brouwer M.C., de Gans J., Heckenberg S.G. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 2009, 9:31-44.
7. Brouwer M.C., Tunkel A.R., van de Beek D. Epidemiology diagnosis and antimicrobial treatment of acute bacterial meningitis. Clin. Microbiol. Rev. 2010, 23:467-492.
8. Brouwer M.C., Read R.C., van de Beek D. Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 2010, 10:262-274.
9. Brouwer M.C., McIntyre P., de Gans J., et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. 2010, 9. [doi], CD004405. http://dx.doi.org/101002/14651858CD004405pub3.
10. Brouwer M.C., Heckenberg S.G., de Gans J., et al. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010, 75:1533-1539.
11. Cronin L., Cook D.J., Carlet J., et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit. Care Med. 1995, 23:1430-1439.
12. Davila S., Wright V.J., Khor C.C., et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 2010, 42:772-776.
13. de Gans J., van de Beek D. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 2002, 347:1549-1556.
14. Dubos F., Korczowski B., Aygun D.A., et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch. Pediatr. Adolesc. Med. 2008, 162:1157-1163.
15. Durand M.L., Calderwood S.B., Weber D.J., et al. Acute bacterial meningitis in adults A review of 493 episodes. N. Engl. J. Med. 1993, 328:21-28.
16. Fitch M.T., van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect. Dis. 2007, 7:191-200.
17. Grande P.O. The "Lund Concept" for the treatment of severe head trauma-physiological principles and clinical application. Intensive Care Med. 2006, 32:1475-1484.
18. Heckenberg S.G., de Gans J., Brouwer M.C., et al. Clinical features outcome and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 2008, 87:185-192.
19. Hoogman M., van de Beek D., Weisfelt M., et al. Cognitive outcome in adults after bacterial meningitis. J. Neurol. Neurosurg. Psychiatry 2007, 78:1092-1096.
20. Hsu H.E., Shutt K.A., Moore M.R., et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 2009, 360:244-256.
21. Kilpi T., Peltola H., Jauhiainen T., et al. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr. Infect. Dis. J. 1995, 14:270-278.
22. Kim K.S. Mechanisms of microbial traversal of the blood-brain barrier. Nat. Rev. Microbiol. 2008, 6:625-634.
23. Korinek A.M., Baugnon T., Golmard J.L. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 2006, 59:126-133.
24. Lorenz S., Koedel U., Pfister H.W. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Crit Care Med 1996, 24:1874-1880.
25. McIntyre P.B., Berkey C.S., King S.M., et al. Dexamethasone as adjunctive therapy in bacterial meningitis A meta-analysis of randomized clinical trials since 1988. JAMA 1997, 278:925-931.
26. Nguyen T.H., Tran T.H., Thwaites G., et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N. Engl. J. Med. 2007, 357:2431-2440.
27. Overweg K., Pericone C.D., Verhoef G.G., et al. Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect. Immun. 2000, 68:4604-4610.
28. Paris M.M., Hickey S.M., Uscher M.I., et al. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 1994, 38:1320-1324.
29. Pelkonen T., Roine I., Cruzeiro M.L., et al. Slow initial beta-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: a randomised controlled trial. Lancet Infect. Dis. 2011, 11:613-621.
30. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 2000, 13:302-317.
31. Peltola H., Roine I., Fernandez J., et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective randomized double-blind placebo-controlled trial. Clin. Infect. Dis. 2007, 45:1277-1286.
32. Proulx N., Frechette D., Toye B., et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005, 98:291-298.
33. Ricard J.D., Wolff M., Lacherade J.C., et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin. Infect. Dis. 2007, 44:250-255.
34. Saez-Llorens X., McCracken G.H. Bacterial meningitis in children. Lancet 2003, 361:2139-2148.
35. Scarborough M., Gordon S.B., Whitty C.J., et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N. Engl. J. Med. 2007, 357:2441-2450.
36. Scheld W.M., Dacey R.G., Winn H.R., et al. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis Alterations with penicillin and methylprednisolone. J. Clin. Invest. 1980, 66:243-253.
37. Scheld W.M., Koedel U., Nathan B., et al. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. 2002, 186(Suppl 2):S225-S233.
38. Singhi S., Jarvinen A., Peltola H. Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatr. Infect. Dis. J. 2008, 27:892-896.
39. Snape M.D., Pollard A.J. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect. Dis. 2005, 5:21-30.
40. Sormunen P., Kallio M.J., Kilpi T., et al. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J. Pediatr. 1999, 134:725-729.
41. Stephens D.S., Greenwood B., Brandtzaeg P. Epidemic meningitis meningococcaemia and Neisseria meningitidis. Lancet 2007, 369:2196-2210.
42. Tebruegge M., Curtis N. Epidemiology etiology pathogenesis and diagnosis of recurrent bacterial meningitis. Clin. Microbiol. Rev. 2008, 21:519-537.
43. Thompson M.J., Ninis N., Perera R., et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006, 367:397-403.
44. Thwaites G.E., Tran T.H. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005, 4:160-170.
45. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 2004, 39:1267-1284.
46. Tuomanen E., Hengstler B., Zak O. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1986, 1:15-32.
47. van de Beek D., de Gans J. Dexamethasone and pneumococcal meningitis. Ann. Intern. Med. 2004, 141:327.
48. van de Beek D., de Gans J. Dexamethasone in adults with community-acquired bacterial meningitis. Drugs 2006, 66:415-427.
49. van de Beek D., Schmand B., de Gans J., et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J. Infect. Dis. 2002, 186:1047-1052.
50. van de Beek D., de Gans J., Spanjaard L., et al. Clinical features and prognostic factors in adults with bacterial meningitis. N. Engl. J. Med. 2004, 351:1849-1859.
51. van de Beek D., de Gans J., McIntyre P., et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect. Dis. 2004, 4:139-143.
52. van de Beek D., de Gans J., Tunkel A.R., et al. Community-acquired bacterial meningitis in adults. N. Engl. J. Med. 2006, 354:44-53.
53. van de Beek D., Weisfelt M., de Gans J., et al. Drug insight: adjunctive therapies in adults with bacterial meningitis. Nat. Clin. Pract. Neurol. 2006, 2:504-516.
54. van de Beek D., Drake J.M., Tunkel A.R. Nosocomial bacterial meningitis. N. Engl. J. Med. 2010, 362:146-154.
55. van de Beek D., Farrar J.J., de Gans J., et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010, 9:254-263.
56. van Deuren M., van Dijke B.J., Koopman R.J., et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 1993, 306:1229-1232.
57. Weisfelt M., de Gans J., van der Poll T., et al. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 2006, 5:332-342.
58. Weisfelt M., Hoogman M., van de Beek D., et al. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann. Neurol. 2006, 60:456-468.
59. Weisfelt M., van de Beek D., Spanjaard L., et al. Clinical features complications and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006, 5:123-129.
60. Weisfelt M., van de Beek D., Spanjaard L., et al. Community-acquired bacterial meningitis in older people. J. Am. Geriatr. Soc. 2006, 54:1500-1507.
61. Weisfelt M., van de Beek D., Spanjaard L., et al. Nosocomial bacterial meningitis in adults: a prospective series of 50 cases. J. Hosp. Infect. 2007, 66:71-78.
62. Weisfelt M., van de Beek D., Spanjaard L., et al. A risk score for unfavorable outcome in adults with bacterial meningitis. Ann. Neurol. 2008, 63:90-97.
63. Whitney C.G., Farley M.M., Hadler J., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 2000, 343:1917-1924.
64. Whitney C.G., Farley M.M., Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 2003, 348:1737-1746.
65. Zoons E., Weisfelt M., de Gans J., et al. Seizures in adults with bacterial meningitis. Neurology 2008, 70:2109-2115.